When should antiretroviral therapy be started in HIV-positive persons? - Wikidata - wikimedia - TriplyDB

When should antiretroviral therapy be started in HIV-positive persons?

When should antiretroviral therapy be started in HIV-positive persons?

http://www.wikidata.org/entity/Q41144887

about

When should antiretroviral therapy be started in HIV-positive persons?

http://www.wikidata.org/entity/Q41144887

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

When should antiretroviral therapy be started in HIV-positive persons?

@en

type

label

When should antiretroviral therapy be started in HIV-positive persons?

@en

prefLabel

When should antiretroviral therapy be started in HIV-positive persons?

@en

P1433

Q41144887-166DB401-E72F-4BEE-9B4D-CD11722CFB4E

P1476

Q41144887-FF62D5BC-26AF-4C73-8A64-79203337D04E

P2860

Q41144887-0E7218F9-052E-43A0-8F5E-3C3289F015F3

Q41144887-14DFBB3F-DE68-42BE-9C7C-1451D24FE849

Q41144887-20556C70-366C-4196-9391-EDB04C32FF0B

Q41144887-257F3A6B-D02A-411E-8DAB-6BB69A9CF9B4

Q41144887-3A7902CA-E56A-4DFD-B990-E0C487608F16

Q41144887-3CF24ABE-2002-4DE8-BD9B-D132A04148B9

Q41144887-48508469-51F9-4B8F-A841-5103A7AB51B5

Q41144887-508CB398-9A70-4472-96D9-BCAE3763C3E9

Q41144887-56C4D8BC-B798-4D86-B449-14CD65D74EB3

Q41144887-60889025-2E82-4DB5-A26F-F75A56CE551F

P304

Q41144887-49358F49-40E2-48F1-A11F-374D630A1855

P31

Q41144887-22B356F5-468C-47AC-AE10-593188AD90ED

Q41144887-7771e517-680a-4f31-b389-8a2d857aed57

P356

Q41144887-9BBD7C81-589D-4003-89D9-14FD081EA966

P478

Q41144887-29EE84F6-A287-477A-A5DC-5D7F03D25AA0

P50

Q41144887-A0BF2AFB-6D3F-48A4-A5B7-3076FB244DB0

P577

Q41144887-C134FCA7-9318-4C7F-988D-CA9E216E3B0A

P698

Q41144887-9B13A24F-1CD7-400F-9DBB-9D6C67E0D1BC

P932

Q41144887-41715A0F-AB2F-420C-BB72-4A2B59B9C7B5

P356

P1433

F1000 medicine reports

P1476

When should antiretroviral therapy be started in HIV-positive persons?

@en

P2860

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals

Effect of early versus deferred antiretroviral therapy for HIV on survival.

When to start antiretroviral therapy

Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection.

Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study.

Do benefits of earlier antiretroviral treatment initiation outweigh harms for individuals at risk for poor adherence?

Changes in the risk of death after HIV seroconversion compared with mortality in the general population.

Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers

Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study

P304

81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3410/M2-81

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21170371

http://www.w3.org/2001/XMLSchema#string

P932

2998833

http://www.w3.org/2001/XMLSchema#string